Advertisement |
Developments in Medicare Part B drug benefits should be top of mind for firms like Amgen, Genentech and Roche, because these companies' U.S. revenues are heavily reliant on Part B drugs
Health Biz: Medicare managed care ramps up Apr 05, 2005
Race for Supply -- the Future of China's Gas Market
China's demand for LNG to soar Jul 26, 2010